This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Oct;47(4):441-3.

doi: 10.1016/j.jhep.2007.07.009. Epub 2007 Jul 30.

Treatment of chronic HCV in advanced liver disease: unmet challenges, reason for optimism

Geoffrey S Jensen, James F Trotter

PMID: 17692987
DOI: 10.1016/j.jhep.2007.07.009

Editorial

Treatment of chronic HCV in advanced liver disease: unmet challenges, reason for optimism

Geoffrey S Jensen et al. J Hepatol. 2007 Oct.

. 2007 Oct;47(4):441-3.

doi: 10.1016/j.jhep.2007.07.009. Epub 2007 Jul 30.

Authors

Geoffrey S Jensen, James F Trotter

PMID: 17692987
DOI: 10.1016/j.jhep.2007.07.009

No abstract available

PubMed Disclaimer

Comment on

Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.
Di Marco V, Almasio PL, Ferraro D, Calvaruso V, Alaimo G, Peralta S, Di Stefano R, Craxì A. Di Marco V, et al. J Hepatol. 2007 Oct;47(4):484-91. doi: 10.1016/j.jhep.2007.04.020. Epub 2007 Jun 27. J Hepatol. 2007. PMID: 17692985 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science